Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 2, 2014
Assessment of interleukin 1β serum level in different responder groups and stages of chronic myeloid leukemia patients on imatinb mesylate therapyBassam Francis Matti, Maysoon Ali Saleem, Shahla'a Fadhil SabirTurkish Journal of Haematology : Official Journal of Turkish Society of Haematology|January 4, 2014
Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center studyBassam Francis Matti, Alaa Fadhil Alwan, Alaa Fadhil AlwanImmunogenetics|December 25, 2022
Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapyShahla'a Fadhil Sabir, Bassam Francis Matti, Wifaq Mahmood Ali AlwatarIndian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 2, 2014
The Efficacy of Fludarabine, High Dose Cytosine Arabinoside with Granulocyte Colony Stimulating Factor (FLAG) Protocol as Salvage Therapy for Refractory/Relapsed Acute Leukemias in Adult Iraqi PatientsAlaa Fadhil Alwan, Bassam Francis Matti, Alaadin Sahham Naji, et al.International Journal of Molecular Sciences|March 28, 2024
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance MechanismsSamir Mouhssine, Nawar Maher, Bassam Francis Matti, et al.Cancers|March 13, 2025
Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell MalignanciesNawar Maher, Samir Mouhssine, Bassam Francis Matti, et al.International Journal of Molecular Sciences|June 28, 2023
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular BiomarkersNawar Maher, Samir Mouhssine, Bassam Francis Matti, et al.Biomedicines|February 27, 2026
Molecular Pathogenesis and Targeted Treatment of Richter TransformationNawar Maher, Amir Karami, Bassam Francis Matti, et al.Transplant Immunology|February 1, 2025
Immune reconstitution with high-dose chemotherapy and autologous stem cell transplantation in refractory and relapsed Hodgkin lymphoma: Prognostic factors and outcome from a single-center experienceFawaz S Yousif, Bassam Francis Matti, Shahla'a Fadhil Sabir, et al.Hematology (Amsterdam, Netherlands)|September 18, 2025
Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopeniaAhmed Mjali, Bassam Francis Matti, Waleed Ghanima, et al.Pageof 1